Tomohiro Era

Title: Tomohiro Era: Innovator in Cationic Lipid Technology

Introduction

Tomohiro Era is a notable inventor based in Japan, recognized for his contributions to the field of cationic lipids. His work focuses on developing compounds that facilitate the introduction of nucleic acids into cells, which has significant implications for gene therapy and biotechnology.

Latest Patents

Tomohiro Era has developed several innovative patents related to cationic lipids. One of his latest inventions involves a compound represented by a specific formula, where R8 is a linear alkenyl chain with 12 to 24 carbon atoms, and R9 is a linear or branched alkyl or alkenyl chain with 8 to 24 carbon atoms. This invention also includes a composition that comprises a nucleic acid and the aforementioned compound, enhancing the delivery of nucleic acids into cells or tissues. Another patent discloses a cationic lipid represented by a different formula, which simplifies the process of introducing nucleic acids into cells. This invention also includes a composition containing the cationic lipid and a nucleic acid, along with a method for using this composition for nucleic acid introduction.

Career Highlights

Throughout his career, Tomohiro Era has focused on advancing the understanding and application of cationic lipids in biotechnology. His innovative approaches have contributed to the development of new methods for gene delivery, which are crucial for various medical applications.

Collaborations

Tomohiro Era has collaborated with notable colleagues, including Takeshi Kuboyama and Tomoyuki Naoi, to further enhance the research and development of cationic lipid technologies.

Conclusion

Tomohiro Era's work in cationic lipid technology represents a significant advancement in the field of gene delivery systems. His innovative patents and collaborations highlight his commitment to improving biotechnological applications.